Symptom burden in lung cancer: management updates
نویسندگان
چکیده
منابع مشابه
Symptom Management in Patients With Lung Cancer
2.13.2. In patients with lung cancer who experience chronic pain, the use of the World Health Background: Many patients with lung cancer will develop symptoms related to their disease process or the treatment they are receiving. These symptoms can be as debilitating as the disease progression itself. To many physicians these problems can be the most diffi cult to manage. Methods: A detailed rev...
متن کاملFatigue in lung cancer patients: symptom burden and management of challenges
Lung cancer (LC) remains the most common cause of cancer death in several countries across the world. Fatigue is the most frequently reported symptom in LC patients throughout the entire course of disease, and all international guidelines recommend early screening for cancer-related fatigue (CRF) and symptoms that can affect patients' quality of life. In patients with LC, fatigue belongs to the...
متن کاملFDG PET in the management of lung cancer
We describe a patient with newly diagnosed limy cancer. Staging was performed with CT and mediastinoscopy. FDG PET scan was performed and confirmed increased metabolic activity in the primary tumor as well as the hilar lymph node. Seven months after initial presentation, the patient was found to have two lytic lesions in the pelvis on plain radiograph. Hone scan was negative but PET demon...
متن کاملUpdates in small cell lung cancer treatment.
Lung cancer is divided into two major histologic types: small cell lung cancer (SCLC) and non-small cell lung cancer. SCLC is rapidly progressive and, without treatment, may be fatal in as few as 12 weeks. Fortunately, SCLC is a very chemotherapy- and radiation-sensitive disease, and a variety of chemotherapy agents have demonstrated activity against it. This article provides an overview of SCL...
متن کاملUpdates in non-small cell lung cancer.
Lung cancer is the leading cause of cancer death in both men and women. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, representing more than 80% of lung cancer diagnoses. Five-year survival remains at 15%, but new strategies for prevention, early detection, and treatment may improve survival rates. This article provides an overview of updates in NSCLC, with an empha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Lung Cancer Management
سال: 2016
ISSN: 1758-1966,1758-1974
DOI: 10.2217/lmt-2016-0001